Nalaganje...

PP69. AN AUDIT OF MYELOSUPPRESSION IN PATIENTS WITH GLIOBLASTOMA RECEIVING SIX WEEKS RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY AT THE CHRISTIE

INTRODUCTION: In the “Stupp” EORTC 26981-22981/NCIC CE3 trial, neutropenia (<1.0x10^9/L) or thrombocytopenia (<50x10^9/L) occurred in 4% and 3% respectively of patients during the concurrent phase, and in 4% and 11% respectively of the 78.5% who proceeded to adjuvant temozolomide. This audit w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Hemming, Mr Ryan, Whitfield, Dr Gillian
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358652/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now293.069
Oznake: Označite
Brez oznak, prvi označite!